Yingjie Li

2.2k citations
55 papers · 1.5k indexed · 1 hit paper · h-index 18
Topics
Epigenetics and DNA Methylation (5 papers)Ion channel regulation and function (4 papers)Amyotrophic Lateral Sclerosis Research (3 papers)

In The Last Decade

Yingjie Li

50 papers receiving 1.5k citations

Hit Papers

Autophagy and multidrug resistance in cancer20172026202020232017100200300400500

Peers

Yingjie Li
Comparison fields: 5 of 110
  • Molecular Biology 944
  • Epidemiology 338
  • Cancer Research 285
  • Oncology 212
  • Pulmonary and Respiratory Medicine 108
Replace Lili Zhang with:
Lili Zhang China
Chuan Liu China
Min‐Wei Chen China
Hao Yan China
İbrahim Tekedereli Türkiye
Chun A. Changou Taiwan
Hailing Yang United States
Shuli Zhao China
Lan Wang China
Takumi Shiraishi Japan
Yingjie Li relative to Lili Zhang China Lili Zhang's profile →
Citations per field
00.5×1.5×
Lili Zhang · 1×
Citations per year

Countries citing papers authored by Yingjie Li

Since Specialization
Citations

This map shows the geographic impact of Yingjie Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingjie Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingjie Li more than expected).

Fields of papers citing papers by Yingjie Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingjie Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingjie Li. The network helps show where Yingjie Li may publish in the future.

Co-authorship network of co-authors of Yingjie Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yingjie Li. A scholar is included among the top collaborators of Yingjie Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingjie Li. Yingjie Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 0
3 0
4 20
5 3
6 1
7 11
8 12
9 6
10 9
11 9
12 15
13 32
14
Autophagy and multidrug resistance in cancerbreakdown →
559
15 27
16 11
17 18
18 22
19 20
20 38

About Yingjie Li

Yingjie Li is a scholar working on Molecular Biology, Cancer Research and Obstetrics and Gynecology, having authored 55 papers that have together received 1.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Ion channel regulation and function (4 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). The work is most often cited by research in Cancer Research (285 citations), Molecular Biology (944 citations) and Reproductive Medicine (100 citations). Yingjie Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Nan Yao, Dongmei Zhang, Wen‐Cai Ye, Nan Hu, Chenran Wang, Yuhe Lei, Zhe‐Sheng Chen, Bing He, Yi Han and Wei‐Min Chen. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026